Prolotherapy vs. Extracorporeal Shock Wave Therapy in Chronic Plantar Fasciitis .
This report has been verified
by one or more authors of the
original publication.
Comparison of Ultrasound-Guided Prolotherapy Versus Extracorporeal Shock Wave Therapy in the Treatment of Chronic Plantar Fasciitis: A Randomized Clinical Trial.
J Foot Ankle Surg . Jan-Feb 2022;61(1):48-52.Twenty nine patients with chronic plantar fasciitis were randomized to receive extracorporeal shockwave therapy (ESWT, n=15) or dextrose prolotherapy (n=15). Outcomes of interest included pain measured using a visual analogue scale (VAS) and function measured with the Roles and Maudsley Scale score (RMS) and the Foot Function Index (FFI). Both groups demonstrated significant improvements in pain and function from baseline. There were no significant differences between groups at both 6 and 12 weeks post intervention.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
